Catalyst
Slingshot members are tracking this event:
FDA Approves Propeller Health's Platform for use with GlaxoSmithKline's (GSK) Dry Powder Inhaler Ellipta in Patients with Asthma
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GSK |
|
|
HKMPF |
|
|
SFE |
|
|
SR One |
|
|
MMM |
|
|
Social Capital |
|
|
Propeller Health |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 07, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Propeller Platform, Dry Powder Inhaler, Ellipta, Asthma, Fda, Approval
